We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unlocking Q3 Potential of Amdocs (DOX): Exploring Wall Street Estimates for Key Metrics
Read MoreHide Full Article
The upcoming report from Amdocs (DOX - Free Report) is expected to reveal quarterly earnings of $1.61 per share, indicating an increase of 2.6% compared to the year-ago period. Analysts forecast revenues of $1.26 billion, representing an increase of 1.6% year over year.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
In light of this perspective, let's dive into the average estimates of certain Amdocs metrics that are commonly tracked and forecasted by Wall Street analysts.
The combined assessment of analysts suggests that 'Geographic Revenue- North America' will likely reach $836.06 million. The estimate points to a change of +0.6% from the year-ago quarter.
Analysts' assessment points toward 'Geographic Revenue- Rest of the world' reaching $225.20 million. The estimate indicates a change of +3.4% from the prior-year quarter.
The average prediction of analysts places 'Geographic Revenue- Europe' at $194.12 million. The estimate indicates a change of +3.6% from the prior-year quarter.
Amdocs shares have witnessed a change of +9.1% in the past month, in contrast to the Zacks S&P 500 composite's -2.9% move. With a Zacks Rank #2 (Buy), DOX is expected outperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Unlocking Q3 Potential of Amdocs (DOX): Exploring Wall Street Estimates for Key Metrics
The upcoming report from Amdocs (DOX - Free Report) is expected to reveal quarterly earnings of $1.61 per share, indicating an increase of 2.6% compared to the year-ago period. Analysts forecast revenues of $1.26 billion, representing an increase of 1.6% year over year.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
In light of this perspective, let's dive into the average estimates of certain Amdocs metrics that are commonly tracked and forecasted by Wall Street analysts.
The combined assessment of analysts suggests that 'Geographic Revenue- North America' will likely reach $836.06 million. The estimate points to a change of +0.6% from the year-ago quarter.
Analysts' assessment points toward 'Geographic Revenue- Rest of the world' reaching $225.20 million. The estimate indicates a change of +3.4% from the prior-year quarter.
The average prediction of analysts places 'Geographic Revenue- Europe' at $194.12 million. The estimate indicates a change of +3.6% from the prior-year quarter.
View all Key Company Metrics for Amdocs here>>>
Amdocs shares have witnessed a change of +9.1% in the past month, in contrast to the Zacks S&P 500 composite's -2.9% move. With a Zacks Rank #2 (Buy), DOX is expected outperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>